Establishment Labs Holdings (ESTA) EBITDA Margin Growth (1y) (2018 - 2026)
Establishment Labs Holdings (ESTA) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 146.00 |
| 10 | Establishment Labs Holdings | 2.20 Bn | 2.13 Bn | 47.71 Mn | 2,115.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,115.00 |
| Mar 31, 2026 | 3,008.00 |
| Dec 31, 2025 | 3,586.00 |
| Sep 30, 2025 | 2,518.00 |
| Jun 30, 2025 | -632.00 |
| Mar 31, 2025 | -1,719.00 |
| Dec 31, 2024 | 2,813.00 |
| Sep 30, 2024 | 2,197.00 |
| Jun 30, 2024 | 706.00 |
| Mar 31, 2024 | -623.00 |
| Dec 31, 2023 | -4,004.00 |
| Sep 30, 2023 | -2,714.00 |
| Jun 30, 2023 | -298.00 |
| Mar 31, 2023 | -304.00 |
| Dec 31, 2022 | -351.00 |
| Sep 30, 2022 | 365.00 |
| Jun 30, 2022 | -1,078.00 |
| Mar 31, 2022 | -759.00 |
| Dec 31, 2021 | 321.00 |
| Sep 30, 2021 | -1,976.00 |